| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.4 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.18 | 0.4 |